Literature DB >> 1083701

Effect of human alpha-antitrypsin in papain-induced emphysema in the hamster.

P A Martorana, N N Share.   

Abstract

The possibility that human alpha1-antitrypsin could effectively prevent development of emphysematous lesions produced in hamsters 7 days after exposure to aerosolized papain (3% for 3 hours) was investigated. Pretreatment with intratracheal human alpha1-antitrypsin prevented the appearance of these lesions in a dose-dependent manner. On the other hand, systemic administration of large doses of human alpha1-antitrypsin failed to prevent papain-induced pulmonary lesions, despite a significant increase in serum trypsin inhibitory capacity. These results suggest that intra-alveolar rather than serum concentrations of human alpha1-antitrypsin are critical for preventing the development of pulmonary emphysema in this animal model. It is interesting that although the mechanism by which human alpha1-antitrypsin prevented the papain-induced lesions is unknown, intratracheally administered human alpha1-antitrypsin similarly prevented the development of pulmonary emphysematous lesions induced by 0.1 mg of porcine pancreatic elastase given intratracheally.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083701     DOI: 10.1164/arrd.1976.113.5.607

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Inactivation of human alpha 1-proteinase inhibitor by thiol proteinases.

Authors:  D Johnson; J Travis
Journal:  Biochem J       Date:  1977-06-01       Impact factor: 3.857

Review 2.  Association of alpha 1-antitrypsin deficiency with lung and liver diseases.

Authors:  M Resendes
Journal:  West J Med       Date:  1987-07

Review 3.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

4.  Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype.

Authors:  D W Cockcroft; R K Tennent; S L Horne
Journal:  Can Med Assoc J       Date:  1981-03-15       Impact factor: 8.262

5.  Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.

Authors:  R M Smith; L D Traber; D L Traber; R G Spragg
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

6.  Limited proteolysis by macrophage elastase inactivates human alpha 1-proteinase inhibitor.

Authors:  M J Banda; E J Clark; Z Werb
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

7.  alpha 1-Antitrypsin deficiency and susceptibility to lung disease.

Authors:  H E Evans; N Bognacki
Journal:  Environ Health Perspect       Date:  1979-04       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.